Literature DB >> 8702039

The effect of placental malaria infection on perinatal mortality in rural Malawi.

J M McDermott1, J J Wirima, R W Steketee, J G Breman, D L Heymann.   

Abstract

Perinatal deaths (fetal or infant deaths from the 28th week of pregnancy up to the seventh day after birth) occur as a result of adverse conditions during pregnancy, labor, and delivery, or in the first few days of life. Placental malaria infection is known to increase the risk of delivery of a low birth weight infant, thus, potentially increasing the risk of perinatal and infant mortality. To better understand the relationship among the adverse events in pregnancy, including placental malaria infection, adverse conditions in labor, and birth weight to perinatal mortality, we investigated the perinatal mortality among a cohort of infants born to rural Malawian women for whom placental malaria infection status and birth weight were documented. Among the 2,063 mother-singleton infant pairs, there were 111 perinatal deaths (53.8 perinatal deaths per 1,000 births). The risk of perinatal death increased as birth weight decreased. Risk factors identified for perinatal mortality among all infants excluding birth weight included abnormal delivery (cesarean section, breech, or vacuum extraction), a history of a late fetal or neonatal death in the most recent previous birth among multiparous women, reactive maternal syphilis serology, nulliparity, and low socioeconomic status. Placental malaria infection was not associated with increased perinatal mortality, but was associated with lower perinatal mortality among normal birth weight (> or = 2,500 g) infants (odds ratio = 0.35, 95% confidence interval = 0.14, 0.92). Interventions to address these risk factors could have a substantial impact on reducing perinatal mortality in this population.

Entities:  

Mesh:

Year:  1996        PMID: 8702039     DOI: 10.4269/ajtmh.1996.55.61

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties.

Authors:  J G Beeson; G V Brown; M E Molyneux; C Mhango; F Dzinjalamala; S J Rogerson
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

2.  Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America.

Authors:  R K Mehlotra; H Fujioka; P D Roepe; O Janneh; L M Ursos; V Jacobs-Lorena; D T McNamara; M J Bockarie; J W Kazura; D E Kyle; D A Fidock; P A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Authors:  Christine Manyando; Rhoda Mkandawire; Lwipa Puma; Moses Sinkala; Evans Mpabalwani; Eric Njunju; Melba Gomes; Isabela Ribeiro; Verena Walter; Mailis Virtanen; Raymond Schlienger; Marc Cousin; Miriam Chipimo; Frank M Sullivan
Journal:  Malar J       Date:  2010-09-01       Impact factor: 2.979

4.  Congenital and neonatal malaria in a rural Kenyan district hospital: an eight-year analysis.

Authors:  Michael K Mwaniki; Alison W Talbert; Florence N Mturi; James A Berkley; Piet Kager; Kevin Marsh; Charles R Newton
Journal:  Malar J       Date:  2010-11-06       Impact factor: 2.979

Review 5.  Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.

Authors:  Denitsa Radeva-Petrova; Kassoum Kayentao; Feiko O ter Kuile; David Sinclair; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2014-10-10

6.  Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors.

Authors:  Deborah Watson-Jones; Helen A Weiss; John M Changalucha; James Todd; Balthazar Gumodoka; Judith Bulmer; Rebecca Balira; David Ross; Kokungoza Mugeye; Richard Hayes; David Mabey
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

7.  Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso.

Authors:  Alphonse Ouédraogo; Alfred B Tiono; Amidou Diarra; Edith C Christiane Bougouma; Issa Nébié; Amadou T Konaté; Sodiomon B Sirima
Journal:  J Trop Med       Date:  2011-11-30

8.  Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.

Authors:  Emma Hughes; Norah Mwebaza; Liusheng Huang; Richard Kajubi; Vy Nguyen; Myaing M Nyunt; Francis Orukan; Moses W Mwima; Sunil Parikh; Francesca Aweeka
Journal:  J Acquir Immune Defic Syndr       Date:  2020-02-01       Impact factor: 3.771

9.  Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV.

Authors:  Chigozie J Uneke
Journal:  Yale J Biol Med       Date:  2007-09

10.  Prevalence of Plasmodium falciparum infection in pregnant women in Gabon.

Authors:  Marielle K Bouyou-Akotet; Denisa E Ionete-Collard; Modeste Mabika-Manfoumbi; Eric Kendjo; Pierre-Blaise Matsiegui; Elie Mavoungou; Maryvonne Kombila
Journal:  Malar J       Date:  2003-06-25       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.